MAGAZINE ARCHIVE

Click the thumbnails below to view the Life Sciences IP Review magazines. 

lsipbio.jpeg

LSIPR Conference Special 2020

This issue focuses largely on COVID 19. Stories of vaccine production, disputes over Gilead’s remdesivir, and the price-gouging of face masks, have evolved as the pandemic took hold. 

Other pandemic-related topics are examined in depth by a selection of top industry authors, topics such as patent procurement and licensing, the UK’s attempt to protect ventilator manufacturers from IP lawsuits, and how nations could fall out over the sharing of vaccines.

Elsewhere, non-pandemic issues—microbiome therapeutics being a particular favourite—are also covered in this action-packed and thought-provoking issue.



lsiprautumn2019_cover-1-.jpg

LSIPR Autumn 2019

  • CRISPR: a licence to heal
  • Antibody patents: the waiting game
  • IP portfolios: the five biggest headaches for in-house counsel
  • M&A: year of the megadeal
  • Pharma: a Mexican tradeoff
  • Divisional applications: procedural manoeuvres pay off


lsipr_bio_2019.jpg

LSIPR Conference Special 2019

  • Precision medicine: The future of healthcare?
  • Medicine man: Shire IP chief talks Takeda
  • Diversity focus: Solving STEM’s gender gap
  • High times: Cannabis marks get creative
  • Seed change: India’s growing GMO battle


lsiprautumn2018_cover.jpg

LSIPR Autumn 2018

  • Patent expiry: 5 drugs bracing for generic competition
  • CJEU on gene-editing
  • I-MAK interview
  • Cannabis and
  • IP SPC export waiver


lsiprbio2018_cover.jpg

LSIPR Conference Special 2018

  • ZFN: a rival to CRISPR
  • Drugs regulation: the post Brexit landscape
  • Fake medicines CRISPR Technology
  • LSPN North America


LSIPR 50 2018

50 Key influencers in the life sciences 2018

  • 50 key influencers in the life sciences
  • Easy to digest with a mixture of profiles and interviews
  • Sections on Government, Legal, Business and Investment


lsiprautumn2017_cover-1-.jpg

LSIPR Autumn 2017

  • Patent extension in Canada
  • Fighting cancer at Aslan
  • Counterfeit drugs
  • PTAB developments


lsiprbio2017_cover.jpg

Life Sciences IP Review Conference Special 2017

  • Brexit and the impact on life sciences,
  • CRISPR; Global IP battleground,
  • Green patents; the fast track to examination


lsipr50_2017_cover.jpg

Life Sciences IP Review Top 50 2017

  • 50 key influencers in the life sciences
  • Easy to digest with a mixture of profiles and interviews
  • Sections on Government, Legal, Business and Investment


lsipr-coversmall.jpg

Life Sciences IP Review Autumn 2016



lsipr50-coversmall.jpg

Life Sciences IP Review Top 50 2016



lsiprbio2016-coversmall.jpg Life Sciences IP Review Conference Special 2016

Highlights:



thumbnail-autumn-lsipr.jpg Life Sciences IP Review Autumn Special 2015

Highlights:



lsipr-bio-2015-cover-lores.jpg

Life Sciences IP Review Conference Special 2015

Highlights:



lsipr-feb15-cover-lowres-1.jpg

LSIPR Newsletter Archive

Find all the monthly editions of the digital magazine here.



lsipr-2-2-cover-lowres.jpg

Life Sciences IP Review Quarterly 2.2

Highlights:



lsipr-2-1-thumbnail.jpg

Life Sciences IP Review Quarterly 2.1

Highlights:



01-ofc-lowres-1-.jpg

Life Sciences IP Review Quarterly 1.4

Highlights:



lsiprq3cover.jpg

Life Sciences IP Review Quarterly 1.3

 Highlights:



lsipr-q2-cover-thumbnail.jpg

Life Sciences IP Review Quarterly 1.2

 Highlights:



lsiprq1coverthumbnail.jpg

Life Sciences IP Review Quarterly 1.1

 Highlights:

  • Adapt or die: surviving the patent cliff
  • Interview with Bayer's chief IP counsel
  • Stem cells: implications of the Brüstle case
  • Priority trap: disclosure in Germany


lsipr-annual-2013-thumbnail.jpg

Life Sciences IP Review Annual 2013

 Highlights:

  • India: a threat to an industry or just misunderstood?
  • Considerations for biopharma under a
    first-inventor-to-file regime
  • Patent protection of traditional knowledge and
    biological material
  • The European take on the Bolar provision


lsipr-annual-2012-thumbnail.jpg

Life Sciences IP Review Annual 2012

 Highlights:

  • Is there life for medical diagnostic patents after
    Prometheus?
  • Out in front: the Boston Cluster
  • India’s first compulsory licence
  • The importance of prior art searches


lsipr-annual-2011-thumbnail.jpg

Life Sciences IP Review Annual 2011

 Highlights:

  • An interview with BIO president Jim Greenwood
  • How shifting IP laws change the global life sciences
    regulatory chessboard
  • Practice points in Israel patent prosecution
  • Clinical trials and stratified medicine—
    Maximising patent exclusivity


lsipr-annual-2010-thumbnail.jpg

Life Sciences IP Review Annual 2010

 Highlights:

  • Myriad issues for gene patents
  • EPO oppositions: a cost-effective
    alternative to litigation
  • Stricter examination requirements in Canada
  • Clarifying patentability for medical and
    surgical developments


lsipr-annual-2009-thumbnail.jpg

Life Sciences IP Review Annual 2009

 Highlights:

  • Questions of human embryo research
  • Patenting trends in the vaccine industry
  • The UK Patents Court:
    a more inventive jurisdiction?
  • The patentability of stem cells


lsipr-annual-2008-thumbnail.jpg

Life Sciences IP Review Annual 2008

 Highlights:

  • Assuring the integrity of a supply chain
    against global threats
  • IP on the smallest scale
  • What makes a good expert witness?
  • Supplementary protection certificates
    for medicinal products


 

LSIPR